Fabrice Chouraqui
Förmögenhet: 185 148 $ per 2026-08-31
Förmögenhet: 185 148 $ per 2026-08-31
Fabrice Chouraqui is currently Chief Executive Officer & Executive Director at Pharming Group NV since 2025 and serves as an Independent Member on the Governors Board at Orano Med SAS. Former roles include Chief Executive Officer & Director at Cellarity Inc. and President at Novartis Pharmaceuticals Corp.
from 2016 to 2019.
Education includes an MBA from INSEAD and graduate and doctorate degrees from Universite Paris Cite.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PHARMING GROUP NV 0,02 % | 2026-03-31 | 161 425 ( 0,02 % ) | 185 148 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| PHARMING GROUP N.V. | Verkställande Direktör | 2025-03-04 |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | President | 2019-01-01 |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Verkställande Direktör | 2025-05-12 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Orano Med SAS
Orano Med SAS BiotechnologyHealth Technology Develops cancer treatment therapeutics | Health Technology |
Universite Paris Cite
Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellarity Inc.
Cellarity Inc. Packaged SoftwareTechnology Services Develops AI-driven platform for drug delivery | Technology Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån